Pasithea Therapeutics Corp. (KTTA) vs Palatin Technologies, Inc. (PTN)

Pasithea Therapeutics Corp. and Palatin Technologies, Inc. are both Biotechnology companies. Pasithea Therapeutics Corp. and Palatin Technologies, Inc. are of similar size ($17.5M and $17.2M). Pasithea Therapeutics Corp. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −47.2%) and the higher return on invested capital (−367.5% vs −942.3%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 10 and Palatin Technologies, Inc. on 5.

Valuation

Metric KTTA PTN Biotechnology median
P/E n/m 2.43 7.88
P/S 32.98 2.99 11.47
P/B 0.32 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.28 n/m 0.74
EV/Sales (61.07) 2.23 10.73
Earnings yield (316.00%) 41.20% (28.84%)
Free cash flow yield (109.92%) (37.93%) (23.03%)

Profitability

Metric KTTA PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (49.26%) 0.00%
Net margin 0.00% (47.22%) 0.00%
Free cash flow margin 0.00% (113.25%) 0.00%
Return on equity (65.49%) (297.25%) (57.72%)
Return on assets (61.97%) (73.72%) (49.22%)
Return on invested capital (367.46%) (942.30%) 0.00%

Growth

Metric KTTA PTN Biotechnology median
Revenue growth (TTM) — 86.46% 5.64%
EPS growth (last fiscal year) 77.07% 68.15% —
Revenue growth, 5-year CAGR — (40.52%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KTTA PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 26.25 5.04 4.73
Net debt to EBITDA 2.74 0.15 0.96

Dividend

Metric KTTA PTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KTTA PTN Biotechnology median
Market cap 17.17m 17.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack